Pattern Genomics, in collaboration with CDC and Focus Diagnostics, had a busy year in infectious disease assay design. The company continued its collaboration with CDC on molecular assays for enteric pathogens with a trio of publications at IMMEM 2016 and ASM 2016. The IMMEM co-publications with CDC featured a simple, single-plex E. coli O157:H7-specific assay [...]
All News Items
Pattern Genomics (Madison, CT) and the Centers for Disease Control and Prevention (CDC, Altanta, GA) will jointly present their research entitled "Development of a Subtyping Assay for Direct Detection and Targeted Sequencing of Shiga toxin-producing Escherichia coli (STEC) from Clinical Samples" at the 1st ASM Conference on Rapid Next-Generation Sequencing and Bioinformatic Pipelines for Enhanced [...]
Madison, Conn. – Oct. 1, 2014 - Pattern Genomics, a biotechnology startup company with a software platform that can analyze thousands of genomes to develop sensitive and specific molecular diagnostics, today announced the launch of research that will help to quickly identify enterovirus D68 (EV-D68). Since mid-August, 500 cases have been confirmed by the Centers [...]
Pattern Genomics and the Centers for Disease Control and Prevention have launched a collaboration to investigate new molecular surveillance tools for identifying Shiga toxin-producing Escherichia coli (STEC) bacteria in clinical samples. Pattern Genomics will use its proprietary Daydreamer™ platform and CDC’s bacterial genomics data to identify sequence targets that are present in STEC but absent [...]
Pattern Genomics, a Madison, CT based startup company, is seeking full-time bioinformatics student interns for summer 2014. Pattern Genomics has developed a proprietary bioinformatics platform called Daydreamer™ for large-scale comparative genomics and molecular diagnostic design. Our initial focus is in infectious disease, where our system allows us to load hundreds of pathogen genomes that are [...]
In this interview with Shelly Kraft from SNNLive, Pattern Genomics' founder Dan Fasulo explains the company's technology and its value in efficient development of molecular diagnostics from next-generation sequencing data. This video was shot at the JP Morgan 32nd Annual Healthcare Conference in San Francisco in January, 2014. http://www.youtube.com/watch?v=Kk-U4Adhv-w
Pattern Genomics will present its first major case study at the ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC on January 29, 2014. In the study, Pattern Genomics' proprietary Daydreamer™ bioinformatics platform was used to generate a qPCR primer set to selectively detect methicillin-resistant Staphylococcus aureus (MRSA). By using over 110 relevant genomes as input [...]
Pattern Genomics raised a round of pre-seed funding from Connecticut Innovations (CI), a quasi-state institution that promotes business in Connecticut. Pattern Genomics received a commitment of $150,000 from CI, with a private donor providing an additional $75,000 match. The funding will be used to further develop and test Pattern Genomics' Daydreamer™ software platform for rapid [...]
Pattern Genomics has accepted an invitation to join MassCONNECT, a program that provides advising and networking opportunities to Boston-area biomedical start-up companies. Program participants are assigned a panel of advisors that mentor the company's executives on its business plan, marketing and fund-raising campaigns, and other strategic initiatives. More information about the program and the participants [...]
